IRX5
Basic information
Region (hg38): 16:54930865-54934485
Links
Phenotypes
GenCC
Source:
- craniofacial dysplasia - osteopenia syndrome (Strong), mode of inheritance: AR
- craniofacial dysplasia - osteopenia syndrome (Limited), mode of inheritance: AR
- craniofacial dysplasia - osteopenia syndrome (Supportive), mode of inheritance: AR
- craniofacial dysplasia - osteopenia syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hamamy syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dental; Musculoskeletal; Neurologic; Ophthalmologic | 17230486; 22581230; 34899143 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IRX5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 29 | 31 | ||||
missense | 53 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 0 | 0 | 54 | 31 | 8 |
Variants in IRX5
This is a list of pathogenic ClinVar variants found in the IRX5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-54930964-A-G | Benign (Nov 12, 2018) | |||
16-54931220-T-C | IRX5-related disorder | Likely benign (Oct 28, 2019) | ||
16-54931254-C-T | Inborn genetic diseases | Uncertain significance (Feb 22, 2023) | ||
16-54931311-G-T | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
16-54931360-C-T | Likely benign (Aug 16, 2022) | |||
16-54931374-C-A | Inborn genetic diseases | Uncertain significance (Feb 10, 2022) | ||
16-54931398-A-G | Inborn genetic diseases | Uncertain significance (Oct 26, 2021) | ||
16-54931400-G-A | Inborn genetic diseases | Uncertain significance (Jun 10, 2022) | ||
16-54931402-C-A | Likely benign (Apr 26, 2023) | |||
16-54931417-C-T | IRX5-related disorder | Likely benign (Apr 30, 2019) | ||
16-54931434-TCTC-T | Craniofacial dysplasia - osteopenia syndrome • Inborn genetic diseases | Uncertain significance (Jun 03, 2022) | ||
16-54931629-C-G | Benign (Nov 12, 2018) | |||
16-54932505-C-T | Inborn genetic diseases | Uncertain significance (Feb 27, 2023) | ||
16-54932509-C-T | Likely benign (Sep 06, 2022) | |||
16-54932513-C-A | Inborn genetic diseases | Uncertain significance (Aug 14, 2023) | ||
16-54932518-A-T | Likely benign (Apr 30, 2018) | |||
16-54932605-C-T | Likely benign (Aug 21, 2023) | |||
16-54932629-C-T | Likely benign (Jun 22, 2018) | |||
16-54932636-G-A | Inborn genetic diseases | Uncertain significance (Jan 10, 2023) | ||
16-54932647-C-G | Inborn genetic diseases | Uncertain significance (Dec 07, 2021) | ||
16-54932668-C-T | Likely benign (Dec 07, 2023) | |||
16-54932686-G-A | Likely benign (Dec 31, 2019) | |||
16-54932696-G-C | Craniofacial dysplasia - osteopenia syndrome | Pathogenic (May 13, 2012) | ||
16-54932746-C-A | Craniofacial dysplasia - osteopenia syndrome | Pathogenic (May 13, 2012) | ||
16-54932749-G-A | Likely benign (Sep 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IRX5 | protein_coding | protein_coding | ENST00000394636 | 3 | 3624 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.975 | 0.0253 | 125288 | 0 | 5 | 125293 | 0.0000200 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.831 | 232 | 270 | 0.858 | 0.0000129 | 3015 |
Missense in Polyphen | 38 | 67.619 | 0.56197 | 741 | ||
Synonymous | -1.42 | 149 | 129 | 1.16 | 0.00000657 | 1057 |
Loss of Function | 3.44 | 1 | 15.7 | 0.0636 | 7.29e-7 | 179 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000296 | 0.0000296 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000555 | 0.0000547 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000266 | 0.0000265 |
Middle Eastern | 0.0000555 | 0.0000547 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Establishes the cardiac repolarization gradient by its repressive actions on the KCND2 potassium-channel gene. Required for retinal cone bipolar cell differentiation. May regulate contrast adaptation in the retina and control specific aspects of visual function in circuits of the mammalian retina (By similarity). Could be involved in the regulation of both the cell cycle and apoptosis in prostate cancer cells. Involved in craniofacial and gonadal development. Modulates the migration of progenitor cell populations in branchial arches and gonads by repressing CXCL12. {ECO:0000250, ECO:0000269|PubMed:22581230}.;
- Disease
- DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- FTO Obesity Variant Mechanism;Preimplantation Embryo
(Consensus)
Recessive Scores
- pRec
- 0.130
Haploinsufficiency Scores
- pHI
- 0.664
- hipred
- hipred_score
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.508
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Irx5
- Phenotype
- growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of heart rate;regulation of transcription by RNA polymerase II;visual perception;gonad development;neuron maturation;embryonic cranial skeleton morphogenesis;response to stimulus;retinal bipolar neuron differentiation
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;vitamin D binding;sequence-specific DNA binding